Only Four UK Pharmacy Chains Providing Meningitis Vaccines During Current Outbreak
Health experts are raising serious concerns about unequal access to meningitis B vaccines, as only four major pharmacy chains in the United Kingdom currently offer the private jabs. This limited availability comes amid a concerning outbreak in Kent that has already claimed the lives of two young people.
Surge in Private Vaccine Bookings
The UK Health Security Agency has confirmed that some cases in the Kent outbreak involve meningitis B, leading to a dramatic increase in private vaccination bookings. Superdrug reported that bookings for their meningitis service have surged to sixty-five times the level seen just one week ago.
Superdrug's spokesperson stated: "At Superdrug, bookings at our nurse clinics for our meningitis service this week have surged to 65 times the level seen last week."
Limited Pharmacy Availability and Pricing
Currently, only four pharmacy chains offer meningitis B vaccines to the public:
- Superdrug: Available for children from two months and adults up to age 50. A course of two to three doses costs £110 per dose.
- Boots: Vaccination service for adults and children aged two and over, costing £220 for two doses.
- Well Pharmacy: Available for children from two months and adults up to age 50, with two to three doses at £110 each.
- Asda: Launched their meningitis vaccine service last year, offering a full menB course for £179.76.
Current Outbreak Situation in Kent
The UKHSA reported on Tuesday, March 17, that there have been fifteen confirmed cases of meningitis in Kent, with four specifically confirmed as meningitis B. Officials continue to investigate the outbreak and will confirm the strain in other cases as laboratory results become available.
In response to the outbreak, hundreds of people who visited Club Chemistry in Canterbury on March 5, 6, or 7 have been advised to come forward for preventative antibiotic treatment as a precautionary measure.
Expert Warnings About Vaccine Access Inequality
Health professionals have expressed serious concerns about the current system creating unequal access to protection based solely on financial means.
Dr Eliza Gil, clinical lecturer at the London School of Hygiene & Tropical Medicine, explained: "Some families choose to access vaccination privately as it is commercially available on the high street from chemists. This creates a situation where currently we have unequal access based on ability to pay."
Professor Andrew Pollard, director of the Oxford Vaccine Group at the University of Oxford, emphasized that while vaccines are important, immediate antibiotic treatment for those exposed should remain the priority. He noted that it takes time for immune responses to develop after vaccination.
NHS Vaccination Programme Limitations
On the National Health Service, the meningitis B vaccine is routinely offered to babies at eight weeks, with follow-up doses at twelve weeks and a booster at one year. However, the majority of young people born before 2015 remain unprotected unless they have obtained the vaccine privately.
The menACWY vaccine, introduced in 2015, protects against four strains of meningococcal bacteria and is offered to teenagers in school settings and those entering university up to age twenty-five.
Supply Chain Challenges and Calls for Reform
The National Pharmacy Association has reported significant supply challenges, with many pharmacies unable to obtain new vaccine orders from wholesalers to meet the sudden increased demand.
NPA chairman Olivier Picard stated: "Many pharmacies across the country have reported to us that they have no supplies of meningitis vaccinations and cannot make new orders from wholesalers. Most pharmacies will have only stocked meningitis vaccinations for a handful of travel vaccination services a year."
The charity Meningitis Now has launched its No Plan B for menB campaign, calling for teenagers and young people to receive meningitis B vaccines through the NHS. They advocate for making these jabs available on the high street at fair prices to ensure broader accessibility.
The NPA has urged the NHS to commission pharmacies to provide catch-up services for teenagers who missed their menACWY vaccines and has called for comprehensive reforms to the childhood vaccination programme to address these critical gaps in protection.
